152 related articles for article (PubMed ID: 28534933)
1. CUEDC2 suppresses glioma tumorigenicity by inhibiting the activation of STAT3 and NF-κB signaling pathway.
Li F; Tang C; Jin D; Guan L; Wu Y; Liu X; Wu X; Wu QY; Gao D
Int J Oncol; 2017 Jul; 51(1):115-127. PubMed ID: 28534933
[TBL] [Abstract][Full Text] [Related]
2. CUEDC2 Protects Against Experimental Colitis and Suppresses Excessive Proliferation of Intestinal Mucosa.
Wang S; Pu J; Li N; Li C; Li C; Yu L; Wang X; Fu S; Cui L
Dig Dis Sci; 2015 Dec; 60(12):3603-9. PubMed ID: 26182901
[TBL] [Abstract][Full Text] [Related]
3. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
[TBL] [Abstract][Full Text] [Related]
4. CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatment.
Zhang H; Chang G; Wang J; Lin Y; Ma L; Pang T
Leuk Res; 2013 Nov; 37(11):1583-91. PubMed ID: 24125838
[TBL] [Abstract][Full Text] [Related]
5. CUEDC2, a novel interacting partner of the SOCS1 protein, plays important roles in the leukaemogenesis of acute myeloid leukaemia.
Wu QY; Zhu YY; Liu Y; Wei F; Tong YX; Cao J; Zhou P; Niu MS; Li ZY; Zeng LY; Li F; Xu KL
Cell Death Dis; 2018 Jul; 9(7):774. PubMed ID: 29991678
[TBL] [Abstract][Full Text] [Related]
6. CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.
Zhang WN; Wang L; Wang Q; Luo X; Fang DF; Chen Y; Pan X; Man JH; Xia Q; Jin BF; Li WH; Li T; Liang B; Chen L; Gong WL; Yu M; Li AL; Zhou T; Li HY
J Biol Chem; 2012 Jan; 287(1):382-392. PubMed ID: 22084247
[TBL] [Abstract][Full Text] [Related]
7. CUEDC2: an emerging key player in inflammation and tumorigenesis.
Man J; Zhang X
Protein Cell; 2011 Sep; 2(9):699-703. PubMed ID: 21976060
[TBL] [Abstract][Full Text] [Related]
8. CUEDC2 controls osteoblast differentiation and bone formation via SOCS3-STAT3 pathway.
Kim JW; Oh SH; Lee MN; Song JH; Jeong BC; Yang JW; Piao X; Zang Y; Ryu JH; Koh JT
Cell Death Dis; 2020 May; 11(5):344. PubMed ID: 32393737
[TBL] [Abstract][Full Text] [Related]
9. Expression of CUEDC2 in colorectal cancer with different invasion and migration abilities.
Hu S; Hu Z; Li S; He C; Wu Y; Teng D; Yan Y; Li H; Xing X; Zou G; Li Y; Yang Y; Wang Y; Du X
J Int Med Res; 2019 Feb; 47(2):905-914. PubMed ID: 30651016
[TBL] [Abstract][Full Text] [Related]
10. Rig-G is a growth inhibitory factor of lung cancer cells that suppresses STAT3 and NF-κB.
Li D; Sun J; Liu W; Wang X; Bals R; Wu J; Quan W; Yao Y; Zhang Y; Zhou H; Wu K
Oncotarget; 2016 Oct; 7(40):66032-66050. PubMed ID: 27602766
[TBL] [Abstract][Full Text] [Related]
11. Rap2B promotes cell adhesion, proliferation, migration and invasion of human glioma.
Miao F; Cui C; Zuo D; Zhang H; Mei P; Chen H; Wei S; Yang F; Zheng J; Bai J; Fan Y
J Neurooncol; 2019 Jun; 143(2):221-229. PubMed ID: 30997639
[TBL] [Abstract][Full Text] [Related]
12. Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma.
Kesanakurti D; Chetty C; Rajasekhar Maddirela D; Gujrati M; Rao JS
Oncogene; 2013 Oct; 32(43):5144-55. PubMed ID: 23178493
[TBL] [Abstract][Full Text] [Related]
13. MiR-18a-downregulated RORA inhibits the proliferation and tumorigenesis of glioma using the TNF-α-mediated NF-κB signaling pathway.
Jiang Y; Zhou J; Zhao J; Hou D; Zhang H; Li L; Zou D; Hu J; Zhang Y; Jing Z
EBioMedicine; 2020 Feb; 52():102651. PubMed ID: 32062354
[TBL] [Abstract][Full Text] [Related]
14. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T
Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969
[TBL] [Abstract][Full Text] [Related]
15. Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1.
Li HY; Liu H; Wang CH; Zhang JY; Man JH; Gao YF; Zhang PJ; Li WH; Zhao J; Pan X; Zhou T; Gong WL; Li AL; Zhang XM
Nat Immunol; 2008 May; 9(5):533-41. PubMed ID: 18362886
[TBL] [Abstract][Full Text] [Related]
16. CTR9-mediated JAK2/STAT3 pathway promotes the proliferation, migration, and invasion of human glioma cells.
Xu Y; Chen J; He G; Zhang Y
J Clin Lab Anal; 2021 Sep; 35(9):e23943. PubMed ID: 34369006
[TBL] [Abstract][Full Text] [Related]
17. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
[TBL] [Abstract][Full Text] [Related]
18. CUEDC2: multifunctional roles in carcinogenesis.
Xiao JB; Leng AM; Zhang YQ; Wen Z; He J; Ye GN
Front Biosci (Landmark Ed); 2019 Mar; 24(5):935-946. PubMed ID: 30844721
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
20. Dobesilate inhibits the activation of signal transducer and activator of transcription 3, and the expression of cyclin D1 and bcl-XL in glioma cells.
Cuevas P; Díaz-González D; Sánchez I; Lozano RM; Giménez-Gallego G; Dujovny M
Neurol Res; 2006 Mar; 28(2):127-30. PubMed ID: 16551428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
